Research ArticleOriginal Article
Medical Abortion in Family Practice: A Case Series
Linda Prine, Ruth Lesnewski, Nancy Berley and Marji Gold
The Journal of the American Board of Family
Practice July 2003, 16 (4) 290-295; DOI: https://doi.org/10.3122/jabfm.16.4.290
Linda Prine
Ruth Lesnewski
Nancy Berley

References
- ↵Termination of pregnancy with reduced doses of mifepristone. World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation. BMJ 1993; 307: 532–7.
- Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Human Reprod 1998; 13: 2962–5.
- Winikoff B, Sivin I, Coyaji K, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 1997; 176: 431–7.
- Winikoff B, Sivin I, Coyaji K, et al. The acceptability of medical abortion in China, Cuba and India. Int Fam Plann Perspect 1997; 23: 73–8.
- ↵Winikoff B, Ellertson C, Elul B, Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group. Arch Fam Med 1998; 7: 360–6.
- ↵Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997; 44: 353–60.
- ↵Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999; 59: 1–6.
- ↵Schaff EA, Fielding SL, Westhoff C, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 2000; 284: 1948–53.
- ↵
- ↵Schaff EA, Fielding SL. A comparison of the abortion rights mobilization and population council trials. J Am Med Womens Assoc 2000; 55(3 Suppl): 137–40.
- ↵Henshaw SK. Abortion incidence and services in the United States, 1995–1996. Fam Plann Perspect 1998; 30: 263–70, 287.
- ↵
- ↵Davis A, Westhoff C, De Nonno L. Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration. J Am Med Womens Assoc 2000; 55(3 Suppl): 141–4.
- ↵
- ↵Kruse B, Poppema S, Creinin MD, Paul M. Management of side effects and complications in medical abortion. Am J Obstet Gynecol 2000; 183(2 Suppl): S68–75.
- ↵Borgatta L, Burnhill M, Haskell S, Nichols M, Leonhardt, K Instituting medical abortion services: changes in outcome and acceptability related to provider experience. J Am Med Womens Assoc 2000; 55(3 Suppl): 173–6.
- ↵Geyman JP, Oliver LM, Sullivan SD. Expectant, medical, or surgical treatment of spontaneous abortion in first trimester of pregnancy? A pooled quantitative literature evaluation. J Am Board Fam Pract 1999; 12: 55–64.
- ↵Nielsen S, Hahlin M, Platz-Christensen J. Randomised trial comparing expectant with medical management for first trimester miscarriages. Br J Obstet Gynaecol 1999; 106: 804–7.
- ↵Coyaji K. Early medical abortion in India: three studies and their implications for abortion services. J Am Med Womens Assoc 2000; 55(3 Suppl): 191–4.
- ↵Elul B, Hajri S, Ngoc NN, et al. Can women in less-developed countries use a simplified medical abortion regimen? Lancet 2001; 5:357: 1402–5.
In this issue
The Journal of the American Board of Family
Practice
Vol. 16, Issue 4
1 Jul 2003
Medical Abortion in Family Practice: A Case Series
Linda Prine, Ruth Lesnewski, Nancy Berley, Marji Gold
The Journal of the American Board of Family
Practice Jul 2003, 16 (4) 290-295; DOI: 10.3122/jabfm.16.4.290
Jump to section
Related Articles
- No related articles found.